candidates from subtype C isolates for a post-RV144 proof-of-concept (POC) Phase I/II trial in Southern Africa, we used a rational selection approach based on several
been used worldwide as an alternative medicine for the treatment of various conditions. This phase II study was to determine the effectiveness of a Mucoadhesive Brazilian propolis ... could be considered as a potential…
underlie the favorable clinical response observed in a cohort of patients enrolled in our phase II liposarcoma trial. Similar results in, breast cancer and glioma cell lines suggest that
sequential and caspase 3 independent activation of DNase I and DNase II. Apatone administration to nude mice significantly reduced tumor growth rate (p<0.05) without inducing significant bone marrow toxicity ... changes…
revealed that some compounds of Ru(II) were capable of changing cell cycle distribution since the percentage of cells in the G1 phases is increased. In addition, treatment with these
chemotherapy or radiation therapy. There are inhibitors of several enzymes in development and Phase I-II clinical trials are being conducted. One of these enzymes is apurinic/apyrimidinic endonuclease
LnCAP cells in vitro more efficiently than Xtandi and ARN-509 (Aragon Pharmaceuticals, Phase II). In prostate cancer xenograft model, ONC1-13B inhibited tumor growth and PSA expression. Activity
develop a self-nanoemulsifying drug delivery system (SNEDDS) for oral bioavailability enhancement of BCS II antifungal drug itraconazole. SNEDDS of itraconazole were developed using NMP as oil, labrasol as surfactant…
compounds presents quite similar chemical structures and undergo quite complex metabolization process mainly of phase II with formation of glucuronide, sulfates and mixed conjugates. Their identification and…
primary tumor) was executed; the unresectable liver metastasizes were diagnosed during the operation (I, II stages of metastatic defeat of liver on the unified classification and confirmed by auxiliary methods…
virtual screening and also screened in house compound library. We found VN/124-1 (Phase II clinical candidate) a potent CYP17 inhibitor as hit with mild ARD and anti-androgen
white crystalline powder, has poor aqueous solubility and bioavailability. It belongs to class II as per BCS classification system. ATR is a potential inhibitor of 3-hydroxy- 3-methyl-glutaryl ... hypercholesterolemia…
initiated a phase I/II clinical trial of a therapeutic prostate cancer vaccine. We have enrolled 12 biopsy confirmed prostate cancer patients in this study and 11 finished the initial ... have led to the creation of the…
situ monitored by use of the COWG sensor. The RI of the lead (II) adlayer with a thickness given as 0.264 nm was determined to be ~1.945 at the maximum ... obtained from the combination of the adlayer-thickness…
Static-lattice atomistic simulations, in vacuum and solvent phase, have been used for the first time to quantify the in silico performance profile of various drug delivery devices and tissue ... respective layers of a…
Phase III trials can be very large. Hence, we may look to find ways to reduce the sample size while still maintaining acceptable Type I and Type II error rates
worldwide. The clinical trials can be divided in various phases which five phases, i.e. 0, I, II, III and IV trials. The present review aims to discuss aboutthe various phases
continuous phase is cured by either physical or chemical means. The main advantages offered by such an approach are: i) high reproducibility of the experiments, ii) a wide variety ... precursor bubbles or droplets and…
acting GH is not toxic in monkeys and the results from clinical trials phases I and II seem to be promising. Designing long acting peptides will diminish the cost
improved health conditions of coronary artery disease (CAD) patients. 80 CAD patients in phase II of the CR program were included in this RCT after admission for PCI or CABG
acting GH is not toxic in monkeys and the results from clinical trials phases I and II seem to be promising. Designing long acting peptides will diminish the cost
Venda’s experimental farm, Thohoyandou over two seasons (season I: February – May 2006; season II: November 2006 – March 2007). The experiments consisted of a factorial combination of P fertilizer rates ... randomized…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.